Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2006 053 971.1 |
96 | EP file number | EAKZ | 15 15 8571.8 |
97 | EP publication number | EPN | 2944688 |
54 | Designation/title | TI | Verwendung von Fettgewebe aus Stromazellen zur Behandlung von Fisteln |
51 | IPC main class | ICM (ICMV) | C12N 5/0775 (2010.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 35/28 (2015.01), A61L 27/38 (2006.01), A61L 24/10 (2006.01), A61B 17/16 (2006.01), A61P 17/02 (2006.01) |
22 | DE application date | DAT | May 16, 2006 |
96 | EP application date | EAT | May 16, 2006 |
43 | Date of first publication | OT | Nov 18, 2015 |
| Date of publication of grant | PET | Oct 25, 2017 |
71/73 | Applicant/owner | INH | Takeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP; Universidad Autónoma de Madrid, Madrid, ES |
72 | Inventor | IN | Fernandez Miguel, Maria Gema, E-28760 Madrid, ES; Gonzalez De La Pena, Manuel Angel, E-28760 Madrid, ES; Garcia Castro, Rosa Ana, E-28760 Madrid, ES; Garcia Arranz, Mariano, E-28049 Madrid, ES; Garcia Olmo, Damian, E-28049 Madrid, ES |
74 | Representative | VTR | Maiwald GmbH, 80335 München, DE |
| Address for service | | Maiwald GmbH, 80335 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 167061 Jun 24, 2005
|
| Due date | FT FG | May 31, 2025 Annual fee for the 20th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002944688 Searchable text:
EP000002944688 Original document:
EP000002944688B1 Searchable text:
EP000002944688B1 |
43 | Date of first publication | EVT | Nov 18, 2015 |
| Date of the first transfer into DPMAregister | EREGT | Nov 19, 2015 |
| Date of the (most recent) update in DPMAregister | REGT | May 17, 2024 (Show all update days)(Hide all update days)- May 17, 2024; Apr 26, 2024; Apr 28, 2023; Oct 24, 2022; Oct 8, 2022; Apr 29, 2022; Apr 24, 2021; May 12, 2020; Aug 20, 2019; May 22, 2019; May 11, 2019; Oct 25, 2018; Sep 20, 2018; Jun 14, 2018; Dec 9, 2017; Dec 7, 2017; Oct 27, 2017; Oct 26, 2017; Apr 13, 2017
- Historical data not available for this/these date(s)
- Nov 19, 2015
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 8)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Oct 7, 2022 |
| Issue number | HN | 46 |
| Year | PJ | 2022 |
| Publication date | VT | Nov 17, 2022 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Takeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP; Universidad Autónoma de Madrid, Madrid, ES |
71/73 | Previous applicant/owner | INHF | TiGenix, S.A.U., Tres Cantos, Madrid, ES, Universidad Autónoma de Madrid, Madrid, ES |
| Date of update of the procedure | REGT | Oct 24, 2022 |